Literature DB >> 4095296

[Extended spinal decompression using an anterior approach in the treatment of myelopathies caused by cervical arthrosis].

J Senegas, J Guérin, J M Vital, B Duplan, J M Dols.   

Abstract

Forty-five patients suffering from severe myelopathy due to cervical spondylosis with stenosis of the spinal canal were treated by anterior decompression extending over three levels or more. In eight instances, the decompression was the only surgical procedure: in 37 instances, there was associated bone graft. No severe complications were noted. The clinical results were assessed, using the Nurick scale. The average follow-up was four years. No patient was made worse. Twelve were completely relieved, 21 were improved and 12 were unchanged. The authors conclude that this technique is worthwhile. Grafting should be done only in cases where there is post-operative instability. After a review of the literature, the authors conclude that anterior resection of the vertebral bodies is more reliable than extensive laminectomy.

Entities:  

Mesh:

Year:  1985        PMID: 4095296

Source DB:  PubMed          Journal:  Rev Chir Orthop Reparatrice Appar Mot        ISSN: 0035-1040


  3 in total

Review 1.  Anterior decompressive microsurgery and osteosynthesis for the treatment of multi-segmental cervical spondylosis. Pathophysiological considerations, surgical indication, results and complications: a survey.

Authors:  V Seifert
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

2.  Intraoperative control by somatosensory evoked potentials in the treatment of cervical myeloradiculopathy. Results in 210 cases.

Authors:  C Sebastián; J P Raya; M Ortega; E Olalla; V Lemos; R Romero
Journal:  Eur Spine J       Date:  1997       Impact factor: 3.134

3.  Results of anterior discectomy without fusion for treatment of cervical radiculopathy and myelopathy.

Authors:  S Tegos; K Rizos; A Papathanasiu; K Kyriakopulos
Journal:  Eur Spine J       Date:  1994       Impact factor: 3.134

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.